Outcomes and Practice Patterns of Long-Acting Injectable Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the United States
The Journal of Clinical Psychiatry · 2026
DOI: 10.4088/jcp.25m16154 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Psychiatry, 2026. Verfasst von Sigal Kaplan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Teva Pharmaceutical Industries Ltd., Netanya, Israel. Hauptthemen laut MEDLINE: Antipsychotic Agents, Bipolar Disorder, Patient Readmission, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Teva Pharmaceutical Industries Ltd., Netanya, Israel.
- Corresponding Author: Sigal Kaplan, PhD, BPharm, Teva Pharmaceutical Industries Ltd, 12 Hatrufa St, Netanya 42504, Israel (sigal.kaplan@teva.co.il).
- eMAX Health Systems, LLC, Delray Beach, Florida.
- Teva UK Limited, Harlow, United Kingdom.
- Teva Branded Pharmaceutical Products R&D LLC, Parsippany, New Jersey.
- Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania.
Zitieren
APA
Kaplan, S., Dotiwala, Z., Casciano, J., Suett, M., Phatak, A., Zhang, Y., Krasenbaum, L., & Sajatovic, M. (2026). Outcomes and Practice Patterns of Long-Acting Injectable Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the United States. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.25m16154
Vancouver
Kaplan S, Dotiwala Z, Casciano J, Suett M, Phatak A, Zhang Y, et al. Outcomes and Practice Patterns of Long-Acting Injectable Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the United States. The Journal of Clinical Psychiatry. 2026. doi:10.4088/jcp.25m16154
BibTeX
@article{Kaplan2026,
author = {Kaplan, Sigal and Dotiwala, Zenobia and Casciano, Julian and Suett, Mark and Phatak, Arti and Zhang, Ying and Krasenbaum, Lynda and Sajatovic, Martha},
title = {Outcomes and Practice Patterns of Long-Acting Injectable Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the United States},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
doi = {10.4088/jcp.25m16154}
}
EUVIMED